These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36948165)

  • 1. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review.
    Wang C; Yuan M; Gao Y; Hou R; Song D; Feng Y
    Oncol Res Treat; 2023; 46(5):177-191. PubMed ID: 36948165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies.
    Zhang Y; Xu J; Zhang N; Chen M; Wang H; Zhu D
    Cancer Lett; 2019 Aug; 458():123-135. PubMed ID: 31121212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer.
    Chen Y; Zheng X; Wu C
    Front Immunol; 2021; 12():792691. PubMed ID: 34925375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Assessment of Recent Immunotherapy for Colorectal Cancer.
    Das S; Acharya D
    Immunol Invest; 2023 Nov; 52(8):1065-1095. PubMed ID: 37812224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
    Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
    World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy.
    Tieng FYF; Lee LH; Ab Mutalib NS
    Front Immunol; 2022; 13():959705. PubMed ID: 36032085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.
    Gomes S; Rodrigues AC; Pazienza V; Preto A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
    Aristin Revilla S; Kranenburg O; Coffer PJ
    Front Immunol; 2022; 13():903564. PubMed ID: 35874729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research Progress in Immunosuppressive Tumor Microenvironment of Gastrointestinal Cancer].
    Li YT; Tan XY; Huang LN; Ma LX; Fu L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):7-14. PubMed ID: 35048593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape.
    Sun XG; Lin XC; Diao JX; Yu ZL; Li K
    Chin J Integr Med; 2016 Oct; 22(10):789-94. PubMed ID: 26556710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on colorectal cancer microenvironment, epigenetic and immunotherapy.
    Jin K; Ren C; Liu Y; Lan H; Wang Z
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107041. PubMed ID: 33045561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer.
    Jin Y; Jiang J; Mao W; Bai M; Chen Q; Zhu J
    Cancer Lett; 2024 Jun; 591():216858. PubMed ID: 38621460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
    Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immune microenvironment and nano-immunotherapeutics in colorectal cancer.
    Xiong Y; Wang Y; Tiruthani K
    Nanomedicine; 2019 Oct; 21():102034. PubMed ID: 31207314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulatory network of the chemokine CCL5 in colorectal cancer.
    Zhang XF; Zhang XL; Wang YJ; Fang Y; Li ML; Liu XY; Luo HY; Tian Y
    Ann Med; 2023 Dec; 55(1):2205168. PubMed ID: 37141250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors.
    Tolba MF
    Int J Cancer; 2020 Dec; 147(11):2996-3006. PubMed ID: 32415713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.